Wednesday, June 21, 2017 1:04:00 PM
CW is extremely pleased with the fact that due to the fortuitous event of Baxalta's being acquired by Shire, MNTA owns the M923 Humira biosimilar 100%. He did, however, mention the difficulty of overcoming the protection afforded by ABBV's more than 100 patents around the drug.
I did relay this group's concerns about the possibility of further dilution, and CW introduced me to Scott Storer the new CFO, who said he doesn't see any need to hit the capital markets again in the near future (with $400MM in the bank and further milestone payments due this year, why would they?).
They treated me like a king, as I was the only stockholder that bothered to attend. BTW, I highly recommend the Kimpton Hotel's valet parking--for anyone considering attending next year.
“It is possible to be a normal decent person and yet to be fully alive.” - George Orwell
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM